Stock Overview
| Snowflake Score | |
|---|---|
| Valuation | -1/6 |
| Future Growth | -1/6 |
| Past Performance | -1/6 |
| Financial Health | -1/6 |
| Dividends | -1/6 |
Price History & Performance
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| DR | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 0.08% | 1.6% | -2.2% |
| 1Y | 64.2% | 14.3% | 8.0% |
Return vs Industry: DR exceeded the Canadian Healthcare industry which returned 14.7% over the past year.
Return vs Market: DR exceeded the Canadian Market which returned 8.5% over the past year.
Price Volatility
| DR volatility | |
|---|---|
| DR Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.2% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: DR's share price has been volatile over the past 3 months.
Volatility Over Time: DR's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Jason Redman | n/a |
Fundamentals Summary
| DR fundamental statistics | |
|---|---|
| Market cap | CA$323.10m |
| Earnings (TTM) | CA$21.78m |
| Revenue (TTM) | CA$610.56m |
14.8x
P/E Ratio0.5x
P/S RatioIs DR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DR income statement (TTM) | |
|---|---|
| Revenue | US$444.59m |
| Cost of Revenue | US$280.39m |
| Gross Profit | US$164.21m |
| Other Expenses | US$148.34m |
| Earnings | US$15.86m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.65 |
| Gross Margin | 36.93% |
| Net Profit Margin | 3.57% |
| Debt/Equity Ratio | 56.5% |
How did DR perform over the long term?
See historical performance and comparison